Finance

Beta
Lists
MNPR:NASDAQ
Monopar Therapeutics Inc
၉၅.၀၃ US$
+၂.၆၄%
(+၂.၄၄) 1D
၉၅.၀၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: ဇူ ၁, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MNPR...
Open
၉၃.၈၃ US$
High
၁၀၀.၃၂ US$
Low
၉၃.၇၄ US$
Mkt. cap
၆၃.၆၆ ကုဋေ
Avg. vol.
၁.၆၁ သိန်း
Volume
၁.၇၈ သိန်း
52-wk high
၁၀၅.၀၀ US$
52-wk low
၂၉.၁၈ US$
EPS
-၁.၉၀ US$
Beta
၁.၅၂
Shares outstanding
၆.၇၀ သန်း
No. of employees
၂၂
Open
၉၃.၈၃ US$
High
၁၀၀.၃၂ US$
Low
၉၃.၇၄ US$
Mkt. cap
၆၃.၆၆ ကုဋေ
Avg. vol.
၁.၆၁ သိန်း
Volume
၁.၇၈ သိန်း
52-wk high
၁၀၅.၀၀ US$
52-wk low
၂၉.၁၈ US$
EPS
-၁.၉၀ US$
Beta
၁.၅၂
Shares outstanding
၆.၇၀ သန်း
No. of employees
၂၂
News stories
From sources across the web
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၁ ရက်
Form 4 Monopar Therapeutics Inc For: 30 June By Investing.com
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၁ ရက်
Monopar Therapeutics (MNPR) director Nicole Sweeny files initial Form 3
About Monopar Therapeutics Inc
CEO-
Employees၂၂
Founded၂၀၁၄
HeadquartersWilmette, အီလီနွိုင်းပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitemonopartx.com
Analyst ratings
Based on 9 analysts giving stock ratings to MNPR in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for MNPR in the last 3 months.
Highest
Current ၉၅.၀၃ US$
၁၃၀.၀၀ US$ (+၃၆.၈၀%)
Average
၁၁၃.၃၃ US$ (+၁၉.၂၆%)
Lowest
၁၀၁.၀၀ US$ (+၆.၂၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chad Messer
Lake Street
Buy
Maintained
၁၀၃.၀၀ US$
+၈.၄%
06/30/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
၁၁၇.၀၀ US$
+၂၃.၁%
07/01/2026
Boris Peaker
JonesTrading
Buy
Maintained
၁၃၀.၀၀ US$
+၃၆.၈%
06/29/2026
Biren Amin
Piper Sandler
Buy
Maintained
၁၀၁.၀၀ US$
+၆.၃%
06/29/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
၁၀၅.၀၀ US$
+၁၀.၅%
06/29/2026
Etzer Darout
Barclays
Buy
Maintained
၁၂၅.၀၀ US$
+၃၁.၅%
06/29/2026
Maxwell Skor
Morgan Stanley
Buy
Maintained
၁၁၅.၀၀ US$
+၂၁%
05/18/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
၁၁၅.၀၀ US$
+၂၁%
05/15/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
၁၀၉.၀၀ US$
+၁၄.၇%
05/14/2026
Soumit Roy
JonesTrading
Buy
Maintained
၁၃၀.၀၀ US$
+၃၆.၈%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၇၃ သန်း
၂.၅၉ သန်း
၃.၉၄ သန်း
၃.၄၉ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၅၀ သန်း
၁.၅၀ သန်း
၂.၂၁ သန်း
၁.၇၄ သန်း
Operating expense
၃.၂၃ သန်း
၄.၀၉ သန်း
၆.၁၆ သန်း
၅.၂၃ သန်း
Total operating expenses
၃.၂၃ သန်း
၄.၀၉ သန်း
၆.၁၆ သန်း
၅.၂၃ သန်း
Operating income
-၃.၂၃ သန်း
-၄.၀၉ သန်း
-၆.၁၆ သန်း
-၅.၂၃ သန်း
Other non operating income
-
၁.၀၀
-၁.၀၀
-
EBT including unusual items
-၂.၄၅ သန်း
-၃.၄၄ သန်း
-၅.၂၀ သန်း
-၃.၈၉ သန်း
EBT excluding unusual items
-၂.၄၅ သန်း
-၃.၄၄ သန်း
-၅.၂၀ သန်း
-၃.၈၉ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၄၅ သန်း
-၃.၄၄ သန်း
-၅.၂၀ သန်း
-၃.၈၉ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၀.၃၅
-၀.၄၈
-၀.၆၁
-၀.၄၆
Interest and investment income
၇.၈၁ သိန်း
၆.၅၅ သိန်း
၉.၅၄ သိန်း
၁.၃၃ သန်း
Interest expense
-
-
-
-
Net interest expenses
၇.၈၁ သိန်း
၆.၅၅ သိန်း
၉.၅၄ သိန်း
၁.၃၃ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer